project id: TCGA-CESC; case submitter id: TCGA-JW-A5VL; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.53; rna integrity number: 9.4; age at index: 37; days to birth: -13604; ethnicity: hispanic or latino; gender: female; race: american indian or alaska native; vital status: Alive; year of birth: 1975; age at diagnosis: 13604; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic t: T1b2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 474.0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 114; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-JW-A5VL-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;